• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

XTL Biopharmaceuticals Ltd

+ Add to Watchlist

XTLB:IT

50.10 ILs 0.30 0.60%

As of 10:24:47 ET on 07/10/2014.

Snapshot for XTL Biopharmaceuticals Ltd (XTLB)

Open: 51.80 Day's Range: 50.00 - 51.80 Volume: 201,202
Previous Close: 49.80 52wk Range: 37.80 - 130.00 1-Yr Rtn: -50.25%

Stock Chart for XTLB

No chart data available.
  • XTLB:IT 50.10
  • 1D
  • 1M
  • 1Y
49.80
Interactive XTLB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XTLB

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.0110
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 118.30
Shares Outstanding (M) 236.13
30 Day Average Volume 144,579
Price/Book (mrq) 5.4298
Price/Sale (ttm) 14.2114
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XTLB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XTLB

XTL Biopharmaceuticals, Ltd. is a biopharmaceutical company. The Company offers acquisition and development of pharmaceutical products for the treatment of unmet medical needs, particularly the treatment of multiple myeloma and hepatitis X.

David GrossmanChief Executive OfficerDavid KestenbaumChief Financial Officer
Moshe MittelmanDirector:Medical
More Company Profile & Key Executives for XTLB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil